Company Description
Nektar Therapeutics touts the therapeutic benefits of inhaling. The company has developed a non-invasive inhaled drug delivery...
Key Nektar Therapeutics Financials
| Company Type | Public - NASDAQ (GS): NKTR Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $273.0 |
| 2007 Employees | 575 |
More Nektar Therapeutics Financials (11 pages)
Latest Nektar Therapeutics Jobs jobs by Indeed
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about Nektar Therapeutics's competition across multiple industries
Top Nektar Therapeutics Competitors
Sponsored Links
The Business Directory
Nektar Therapeutics Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Robert B. Chess | Network | E-mail |
| President, CEO, and Director | Howard W. Robin | Network | E-mail |
| VP Corporate Development | Christopher J. Searcy | Network | E-mail |
More Nektar Therapeutics Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Nektar Therapeutics News
- SECURITIES AND EXCHANGE COMMISSION NEWS DIGEST [SEC News Digest] (21 Aug 2008 00:01:00 EDT)
- BioWorld Today August 8, 2008 [BioWorld Today] (08 Aug 2008 00:01:00 EDT)
- Briefing.com: Hourly In Play (R) - 23:00 ET [Briefing.com] (07 Aug 2008 23:00:00 EDT)
Sponsored Opportunity
